SCHEMBL8912147

SCHEMBL8912147

CCCN(CCC1Cc2ccc(-c3ccc(=O)[nH]n3)cc2C1)C(=O)c1cccnc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.40
TLR8 Q9NR97 2/20 0.35
TLR7 Q9NYK1 2/20 0.35
MAPT P10636 1/20 0.35
NPSR1 Q6W5P4 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CYP1A2 P05177 2/20 0.34
GRIA2 P42262 1/20 0.34
HSD17B10 Q99714 2/20 0.34
PDE3B Q13370 2/20 0.33
PDE3A Q14432 2/20 0.33
HTT P42858 1/20 0.33
MCHR1 Q99705 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HRH3 Q9Y5N1 1/20 0.32
PARP1 P09874 1/20 0.32
PDE4A P27815 1/20 0.32
PDE4B Q07343 1/20 0.32
PDE4C Q08493 1/20 0.32
PDE4D Q08499 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8913328 0.81 MAPT (0.38) MAPTCYP1A2PDE3BPDE3AHRH3
SCHEMBL8912491 0.80 HDAC3 (0.40) CYP1A2CYP3A4CYP2C9DYRK1A
SCHEMBL8912991 0.78 ALDH1A1 (0.41) L3MBTL1CYP1A2GRIA2ALDH1A1
SCHEMBL8913213 0.76 MAPT (0.39) MAPTCYP1A2PDE3BPDE3AHRH3
SCHEMBL8292401 0.72 GRIA2 (0.41) CYP1A2GRIA2PDE3BPDE3A
SCHEMBL8292411 0.71 PDE3B (0.42) MAPTCYP1A2GRIA2PDE3BPDE3A
SCHEMBL28527737 0.71 HTT (0.57) KDM4EMAPTNPSR1L3MBTL1CYP1A2
SCHEMBL8911327 0.70 P2RX7 (0.39) CYP1A2PDE3BPDE3APARP1PDE4A
Bromide SCHEMBL8298175 0.70 PDE3B (0.41) MAPTCYP1A2GRIA2PDE3BPDE3A
SCHEMBL8911880 0.70 PDE3B (0.39) MAPTCYP1A2PDE3BPDE3AHRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5605901-A THERAPY FOR GRAM-NEGATIVE BACTERIA, NEPHRITIS TANABE SEIYAKU CO., LTD. (JP) 1997-02-25 US claimed
US-5543409-A Indane derivatives for treating endotoxin shock and/or nephritis TANABE SEIYAKU CO., LTD. (JP) 1996-08-06 US claimed
EP-0661274-A1 Indane derivatives, processes for preparing the same and synthetic intermediate of the same TANABE SEIYAKU CO., LTD. (JP) 1995-07-05 EP claimed